The Medipattern Corporation (TSX VENTURE: MKI), an award-winning developer of computer-aided diagnosis (CAD) software, whose mission is to reduce the number of unnecessary biopsies performed to diagnose cancer, is pleased to announce the signing of distribution agreements with Electronica y Medicina, S.A. (EYMSA), headquartered in Mexico; D.F., Mexico; and Dong Jin Medical Co., Ltd., based in Seoul, Korea. These agreements are part of Medipattern's comprehensive strategy to establish a global distribution network for its products.
